Two more COVID-19 vaccines move towards Phase 2 human trials
Hot on the heels of biotech company Moderna’s recent announcement of successful phase 1 trials for its mRNA COVID-19 vaccine, two more promising candidates are delivering encouraging early data as several vaccines race into phase 2 human testing. Source of Article